Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 3/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.44 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17970089 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL16607543 | 1.00 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL2661927 | 0.74 | NPSR1 (0.50) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL21449886 | 0.74 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL676110 | 0.74 | NPSR1 (0.50) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL3108916 | 0.74 | ALDH1A1 (0.47) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL8249002 | 0.74 | ALDH1A1 (0.39) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL8620015 | 0.73 | ALDH1A1 (0.53) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL17532418 | 0.72 | ALDH1A1 (0.57) | ALDH1A1LMNATSHRKMT2AHSD17B10 | |
| SCHEMBL13169805 | 0.72 | CA9 (0.44) | ALDH1A1LMNATSHRKMT2AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 490 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114805043-A | Preparation method and system of cyclopentanone | 中国石油化工股份有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114805042-A | Method and system for preparing cyclopentanone and application thereof | 中国石油化工股份有限公司 | 2022-07-29 | — | — | CN | claimed |
| US-20250059191-A1 | CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION PROCESS THEREOF | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2025-02-20 | — | — | US | disclosed |
| US-12221443-B2 | Crystalline forms of diazabicyclooctane derivative and production process thereof | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2025-02-11 | — | — | US | disclosed |
| US-20220348578-A1 | CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION PROCESS THEREOF | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2022-11-03 | — | — | US | disclosed |
| US-11414417-B2 | Crystalline forms of diazabicyclooctane derivative and production process thereof | MEIJI SEIKA PHARMA CO., LTD. (JP) | 2022-08-16 | — | — | US | disclosed |
| CN-114805043-A | Preparation method and system of cyclopentanone | 中国石油化工股份有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114805042-A | Method and system for preparing cyclopentanone and application thereof | 中国石油化工股份有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114057620-A | Method and system for preparing hydrogen peroxide cyclopentylbenzene by cyclopentene | 中国石油化工股份有限公司 | 2022-02-18 | — | — | CN | disclosed |
| US-11213804-B2 | Dehydrogenation catalysts and methods of making and using the same | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2022-01-04 | — | — | US | disclosed |
| CN-113698332-A | Method for preparing hydrogen peroxide cyclopentylbenzene from cyclopentylbenzene | 中国石油化工股份有限公司 | 2021-11-26 | — | — | CN | disclosed |
| US-20030176733-A1 | Method for oxidizing hydrocarbons | CREAVIS GESELLSCHAFT FUER TECHNOLOGIE UND INNOVATION MBH (DE) | 2003-09-18 | — | — | US | disclosed |
| US-20030083527-A1 | Method for producing aromatic alcohols, especially phenol | CREAVIS GESELLSCHAFT FUER TECHNOLOGY UND INNOVATION MBH (DE) | 2003-05-01 | — | — | US | disclosed |
| US-6316639-B1 | REACTING DICARBOXYLIC ACIDS OR ANHYDRIDES WITH A SALT OF HYDROXYL-AMINE IN SOLUTION SELECTED FROM HYDROXYLAMINE SULFATE, HYDROXYLAMINE NITRATE, HYDROXYLAMINE ACETATE, HYDROXYLAMINE TETRAFLUOROBORATE, HYDROXYLAMINE PHOSPHATE | Consortium für elektrochemische Industrie GmbH (DE) | 2001-11-13 | — | — | US | disclosed |
| US-6297403-B1 | OXIDATION OF A (DI)ARYL METHANE OR METHYLENE DERIVATIVE IN PRESENCE OF AN AMINE OXIDE OR HYDROXYAMINE DERIVATIVE MEDIATOR; BY-PRODUCT INHIBITION | Consortium für elektrochemische Industrie GmbH (DE) | 2001-10-02 | — | — | US | disclosed |
| US-6242245-B1 | DELIGNIFICATION BY ADDING SUSPENSION OF LACCASE, OXIDANT, MEDIATOR SUCH AS VIOLURIC ACID, AND XYLANASE TO AQUEOUS SUSPENSION OF LIGNIN MATERIAL AND MIXING; MEDIATOR DOES NOT DEACTIVATE ENZYME | Consortium für elektrochemische Industrie GmbH (DE) | 2001-06-05 | — | — | US | disclosed |
| US-6187170-B1 | SYSTEM FOR THE ELECTROCHEMICAL CLEAVAGE OF COMPOUNDS WHICH INCLUDES A MEDIATOR AND AT LEAST TWO ELECTRODES FOR THE ELECTROCHEMICAL ACTIVATION OF THE MEDIATOR | Consortium für elektrochemische Industrie GmbH (DE) | 2001-02-13 | — | — | US | disclosed |
| US-6169213-B1 | REACTING A HETEROARYL METHANOL WITH AN OXIDANT AND A MEDIATOR CONTAINING AMINO OXIDE GROUP TO FORM HETEROARYL ALDEHYDE OR A HETEROARYL KETONE | Consortium f{umlaut over (u)}r elektrochemische Industrie GmbH (DE) | 2001-01-02 | — | — | US | disclosed |
| US-6069282-A | REACTION OF VINYL-, ALKYNYL- OR ARYL-METHANOLS WITH THE AID OF A MEDIATOR AND AN OXIDANT, WHEREIN THE MEDIATOR IS SELECTED FROM THE GROUP OF THE ALIPHATIC, CYCLOALIPHATIC, HETEROCYCLIC OR AROMATIC NO OR NOH CONTAINING COMPOUNDS | CONSORTIUM FUR ELEKTROCHEMISCHE INDUSTRIE GMBH (DE) | 2000-05-30 | — | — | US | disclosed |
| US-6023000-A | Process for the preparation of aldehydes and ketones | Consortium fur elektrochemisch Industrie GmbH (DE) | 2000-02-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220348578-A1 | CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION PROCESS THEREOF | CCNA1, RCC1, DDT | ALDH1A1 1981/4885LMNA 1261/4885TSHR 3422/4885 |
| US-20250059191-A1 | CRYSTALLINE FORMS OF DIAZABICYCLOOCTANE DERIVATIVE AND PRODUCTION PROCESS THEREOF | CCNA1, RCC1, DDT | ALDH1A1 1981/4885LMNA 1261/4885TSHR 3422/4885 |
| US-20030176733-A1 | Method for oxidizing hydrocarbons | CBR1, CBR3, SCO2 | ALDH1A1 891/4885LMNA 1581/4885TSHR 2242/4885 |
| US-11213804-B2 | Dehydrogenation catalysts and methods of making and using the same | IDH2, ADH4, IDH1 | ALDH1A1 245/4885LMNA 2533/4885TSHR 3911/4885 |
| US-12221443-B2 | Crystalline forms of diazabicyclooctane derivative and production process thereof | CCNA1, RCC1, DDT | ALDH1A1 1981/4885LMNA 1261/4885TSHR 3422/4885 |
| US-20030083527-A1 | Method for producing aromatic alcohols, especially phenol | CYP2E1, AOC2, ADH1C | ALDH1A1 330/4885LMNA 762/4885TSHR 1479/4885 |
| US-11414417-B2 | Crystalline forms of diazabicyclooctane derivative and production process thereof | CCNA1, RCC1, DDT | ALDH1A1 1981/4885LMNA 1261/4885TSHR 3422/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.